These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 29934505)

  • 1. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
    Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
    Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
    Shao N; Lu Z; Zhang Y; Wang M; Li W; Hu Z; Wang S; Lin Y
    Cancer Lett; 2015 Aug; 364(2):165-72. PubMed ID: 25979232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL2/CCR2 axis induces hepatocellular carcinoma invasion and epithelial-mesenchymal transition in vitro through activation of the Hedgehog pathway.
    Zhuang H; Cao G; Kou C; Liu T
    Oncol Rep; 2018 Jan; 39(1):21-30. PubMed ID: 29115520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling.
    Hu WT; Li MQ; Liu W; Jin LP; Li DJ; Zhu XY
    Mol Hum Reprod; 2014 Apr; 20(4):358-72. PubMed ID: 24344240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells.
    Chiu HY; Sun KH; Chen SY; Wang HH; Lee MY; Tsou YC; Jwo SC; Sun GH; Tang SJ
    Cytokine; 2012 Aug; 59(2):423-32. PubMed ID: 22617682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting CCL2-CCR2 signaling pathway alleviates macrophage dysfunction in COPD via PI3K-AKT axis.
    Dong Y; Dong Y; Zhu C; Yang L; Wang H; Li J; Zheng Z; Zhao H; Xie W; Chen M; Jie Z; Li J; Zang Y; Shi J
    Cell Commun Signal; 2024 Jul; 22(1):364. PubMed ID: 39014433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells.
    Nam JS; Kang MJ; Suchar AM; Shimamura T; Kohn EA; Michalowska AM; Jordan VC; Hirohashi S; Wakefield LM
    Cancer Res; 2006 Jul; 66(14):7176-84. PubMed ID: 16849564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.
    Yao M; Fang W; Smart C; Hu Q; Huang S; Alvarez N; Fields P; Cheng N
    Mol Cancer Res; 2019 Feb; 17(2):604-617. PubMed ID: 30446625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
    Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M
    Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T; Gomes A
    Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells.
    Rabi T; Huwiler A; Zangemeister-Wittke U
    Mol Carcinog; 2014 Jul; 53(7):578-88. PubMed ID: 23475563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms.
    Fang WB; Jokar I; Zou A; Lambert D; Dendukuri P; Cheng N
    J Biol Chem; 2012 Oct; 287(43):36593-608. PubMed ID: 22927430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
    Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
    Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
    Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C
    Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms.
    Brummer G; Acevedo DS; Hu Q; Portsche M; Fang WB; Yao M; Zinda B; Myers M; Alvarez N; Fields P; Hong Y; Behbod F; Cheng N
    Mol Cancer Res; 2018 Feb; 16(2):296-308. PubMed ID: 29133591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBP induces the expression of monocyte chemoattractant protein-1 via the FAK/PI3K/AKT and p38 MAPK/NF-κB pathways in vascular endothelial cells.
    Chang M; Guo F; Zhou Z; Huang X; Yi L; Dou Y; Huan J
    Cell Signal; 2018 Mar; 43():85-94. PubMed ID: 29288710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of estrogen-induced apoptosis in breast cancer cells: role of the NF-kappaB signaling pathway.
    Lobanova YS; Scherbakov AM; Shatskaya VA; Krasil'nikov MA
    Biochemistry (Mosc); 2007 Mar; 72(3):320-7. PubMed ID: 17447886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis.
    Izhak L; Wildbaum G; Jung S; Stein A; Shaked Y; Karin N
    PLoS One; 2012; 7(1):e28305. PubMed ID: 22279523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways.
    He M; Yu W; Chang C; Miyamoto H; Liu X; Jiang K; Yeh S
    Mol Oncol; 2020 Aug; 14(8):1779-1799. PubMed ID: 32356397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.